rs905678829
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001136263.2(C2CD4C):c.946G>C(p.Glu316Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000243 in 1,524,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001136263.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 152050Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000168 AC: 2AN: 119302Hom.: 0 AF XY: 0.0000153 AC XY: 1AN XY: 65562
GnomAD4 exome AF: 0.0000124 AC: 17AN: 1371890Hom.: 0 Cov.: 31 AF XY: 0.0000177 AC XY: 12AN XY: 676130
GnomAD4 genome AF: 0.000131 AC: 20AN: 152162Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.946G>C (p.E316Q) alteration is located in exon 2 (coding exon 1) of the C2CD4C gene. This alteration results from a G to C substitution at nucleotide position 946, causing the glutamic acid (E) at amino acid position 316 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at